Touch Medical Media coverage of data presented at EADV 2021:
In this interview, we talk with Dr Brian Kim (Washington University School of Medicine, St. Louis, MO, USA) about the current unmet need in the treatment of pruritus and how the therapeutic landscape is changing.
His presentation entitled ‘New frontiers in itch therapy‘ was given at the EADV 30th Congress, 29 Sep – 2 Oct 2021.
Questions
- Could you give us an overview of the health burden of chronic pruritus in atopic dermatitis and the unmet needs in its treatment? (0:17)
- How are recent advances changing the therapeutic landscape for pruritus? (1:17)
Disclosures: Dr Brian Kim has acted as a consultant for AbbVie, AstraZeneca, Cara Therapeutics, Galderma, GlaxoSmithKline, LEO Pharma, Eli Lilly, Pfizer, Regeneron, Sanofi and Trevi Therapeutics and undertaken contracted research for Cara Therapeutics and LEO Pharma.
Support: Interview and filming supported by Touch Medical Media. Interview conducted by Gina Furnival.
Filmed in coverage of the EADV’s 30th Congress, 29 Sep – 2 Oct 2021.
This content was developed by Touch Medical Media and is not affiliated with the European Academy of Dermatology & Venereology (EADV) or the congress.